News

News

Hikma continues strong 2021 performance and reiterates full year guidance

News

News

Hikma and Almirall enter an exclusive licensing agreement to market Finjuve in the Middle East and North Africa region

Recent event

Recent event

Watch the replay of our Generics Meet the Management event.

2021 Interim Results

Watch our CEO Siggi Olafsson summarise our 2021 half year performance

#OwnYour Career @Hikma

#OwnYour Career @Hikma

Meet Janaina, Maintenance Planner, Engineering at Hikma Portugal. She loves tackling new challenges every day and using her communications and problem solving skills on the job.

Case study

Case study

Our support and impact; improving patient’s access to ritonavir

Insight

Insight

Kept out of reach - tackling the enduring challenge of access to medicine

Update

Update

Hikma update regarding COVID-19

Find out more

Who we are. We make high quality medicines and make them accessible to the people that need them.

News

News

Hikma Pharmaceuticals and Sesen Bio announce exclusive partnership to commercialise Vicineum™ in MENA

Find out more

Find out more

Our commitment to sustainability

Find out more

Find out more

Our Modern Slavery Act statement.